ESC 365 - Comorbidities and excess mortality of patients with moderate mitral regurgitation

ESC2025 Premium Access

Comorbidities and excess mortality of patients with moderate mitral regurgitation

Session: Mitral regurgitation and clinical consequences

Topic: Mitral Valve Regurgitation

Speaker: Doctor S. Elimeleh (Ramat Gan, IL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Shir Elimeleh

Sheba Medical Center, Ramat Gan (Israel)

0 follower

5 more presentations in this session

Prevalence, clinical significance, and risk factors of arrhythmic mitral valve prolapse - results of the MITPROL AR-PL Registry.

Speaker: Doctor D. Dziadosz (Katowice, PL)

Prognostic impact of resting and exercise right ventricular to pulmonary artery coupling in patients with dynamic mitral regurgitation

Speaker: Doctor J. Glasmacher (Duesseldorf, DE)

Sex-specific patterns in worldwide burden of non-rheumatic degenerative mitral valve disease between 1990 and 2021, results from the Global Burden of Disease Study 2021

Speaker: Doctor J. Ma (Beijing, CN)

The REVEAL-AFMR score: development and validation of a prognostic model for patients with atrial functional mitral regurgitation

Speaker: Doctor H. Kago (Tokyo, JP)

Predictors of mitral regurgitation improvement in functional mitral regurgitation: insights from ventricular and atrial remodeling

Speaker: Doctor C. Lu (Taoyuan, TW)

Access the full session

Mitral regurgitation and clinical consequences

Speakers: Doctor S. Elimeleh, Doctor D. Dziadosz, Doctor J. Glasmacher, Doctor J. Ma, Doctor H. Kago...

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources